OptiNose Stock (NASDAQ: OPTN) stock price, news, charts, stock research, profile.
Open | $0.951 |
Close | $0.925 |
Volume / Avg. | 571.325K / 610.589K |
Day Range | 0.891 - 0.963 |
52 Wk Range | 0.855 - 2.100 |
Market Cap | $107.109M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 27 |
Short Interest | 3.19% |
Days to Cover | 2.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of OptiNose (NASDAQ: OPTN) through any online brokerage.
Other companies in OptiNose’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS), Rani Therapeutics Hldgs (NASDAQ:RANI), Marinus Pharma (NASDAQ:MRNS) and Alimera Sciences (NASDAQ:ALIM).
The latest price target for OptiNose (NASDAQ: OPTN) was reported by Lake Street on Monday, March 18, 2024. The analyst firm set a price target for 4.00 expecting OPTN to rise to within 12 months (a possible 320.70% upside). 5 analyst firms have reported ratings in the last year.
The stock price for OptiNose (NASDAQ: OPTN) is $0.9508 last updated April 24, 2024 at 9:25 AM EDT.
There are no upcoming dividends for OptiNose.
OptiNose’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for OptiNose.
OptiNose is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.